Novavax, Inc. (LON:0A3S)
London flag London · Delayed Price · Currency is GBP · Price in USD
8.00
-0.27 (-3.21%)
At close: Feb 5, 2026

Novavax Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9451,0294487347,9892,987
Market Cap Growth
-17.75%129.81%-38.98%-90.82%167.41%4139.68%
Enterprise Value
5675121402496,8973,099
Last Close Price
5.916.303.818.05115.8187.43
PS Ratio
1.191.890.580.459.448.58
PB Ratio
-8.10-2.06-0.79-1.39-30.766.50
P/TBV Ratio
-----8.39
P/FCF Ratio
----40.30-
P/OCF Ratio
----33.50-
EV/Sales Ratio
0.720.940.180.158.158.90
EV/FCF Ratio
-1.98---34.79-
Debt / Equity Ratio
-1.60-0.42-0.39-0.97-1.490.77
Debt / FCF Ratio
----1.95-
Asset Turnover
0.740.410.490.820.550.54
Inventory Turnover
39.0122.5926.4790.94--
Quick Ratio
1.850.890.530.580.821.68
Current Ratio
2.270.980.700.690.902.15
Return on Equity (ROE)
-----1265.71%-189.60%
Return on Assets (ROA)
18.01%-8.63%-17.02%-16.67%-50.69%-29.48%
Return on Capital Employed (ROCE)
55.60%-57.10%-340.10%320.30%-904.70%-41.30%
Earnings Yield
26.92%-14.56%-95.59%-74.44%-16.12%-10.25%
FCF Yield
-30.22%-7.79%-134.64%-57.14%2.48%-2.38%
Buyback Yield / Dilution
-16.16%-51.03%-28.89%-5.08%-29.27%-138.81%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.